On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, ...

As part of the three-year agreement, Gilead has agreed to take a series of actions that align with the government’s new drug ...

Novartis has announced an agreement with the US government to lower the prices of its medicines in the US and support ...

Merck (known as MSD outside the US) has announced an agreement with the US government to provide key products to patients at ...

Novo Nordisk’s Wegovy (semaglutide) pill has been approved by the US FDA as an oral weight loss medication. In addition to ...

Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story ...

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more to find out.

Pfizer has announced results from its phase 3 BASIS study of Hympavzi (marstacimab), demonstrating its success in reducing bleeds in adults and adolescents living with haemophilia A or B with ...

Roche has received clearance from the US Food and Drug Administration (FDA) for its point of care diagnostic test for whooping cough (pertussis) and other Bordetella infections. The test also received ...

Regeneron Pharmaceuticals’ Libtayo (cemiplimab) has received approval from the European Commission for the adjuvant treatment of cutaneous squamous cell carcinoma (CSCC) with high risk of recurrence ...

ESMO celebrates 50 years of focusing on oncology research; Improving cardiovascular disease therapy; Global pharma pricing impact on supply chains ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced plans to deepen its collaboration with the US Food and Drug Administration (FDA) to enhance patient access to ...